Shares of Avacta Group Plc (LON:AVCT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 57.07 ($0.74) and traded as high as GBX 61 ($0.79). Avacta Group shares last traded at GBX 56 ($0.73), with a volume of 1,710,026 shares changing hands.
Avacta Group Stock Performance
The company has a debt-to-equity ratio of 63.54, a quick ratio of 4.96 and a current ratio of 1.29. The stock’s fifty day moving average price is GBX 63.46 and its 200-day moving average price is GBX 57.07. The company has a market capitalization of £200.65 million, a P/E ratio of -622.22 and a beta of 1.12.
Insider Activity
In other news, insider Tony Peter Gardiner sold 500,000 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of GBX 71 ($0.92), for a total value of £355,000 ($460,919.24). 32.90% of the stock is owned by insiders.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Learn Technical Analysis Skills to Master the Stock Market
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Calculate Return on Investment (ROI)
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.